Quadrant Capital Group’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-128
Closed -$6.08K 2495
2026
Q1
$6.08K Sell
128
-28
-18% -$1.25K ﹤0.01% 2313
2025
Q4
$4.95K Hold
156
﹤0.01% 2381
2025
Q3
$4.39K Buy
+156
New +$4.72K ﹤0.01% 2340
2025
Q2
Sell
-156
Closed -$6.13K 2541
2025
Q1
$6.13K Hold
156
﹤0.01% 2317
2024
Q4
$7.25K Sell
156
-59
-27% -$2.67K ﹤0.01% 2215
2024
Q3
$9.71K Buy
215
+59
+38% +$2.81K ﹤0.01% 2151
2024
Q2
$7.69K Buy
156
+10
+7% +$408 ﹤0.01% 2193
2024
Q1
$5.01K Hold
146
﹤0.01% 2312
2023
Q4
$5.38K Sell
146
-74
-34% -$1.71K ﹤0.01% 2258
2023
Q3
$4.46K Sell
220
-33
-13% -$725 ﹤0.01% 2209
2023
Q2
$5.18K Buy
253
+196
+344% +$2.94K ﹤0.01% 2191
2023
Q1
$860 Sell
57
-14
-20% -$309 ﹤0.01% 2555
2022
Q4
$1.69K Sell
71
-280
-80% -$8.12K ﹤0.01% 2457
2022
Q3
$12K Sell
351
-5
-1% -$212 ﹤0.01% 1815
2022
Q2
$12K Buy
356
+353
+11,767% +$12.5K ﹤0.01% 1573
2022
Q1
$0 Sell
3
-2
-40% -$111 ﹤0.01% 2700
2021
Q4
$0 Sell
5
-86
-95% -$8.83K ﹤0.01% 2700
2021
Q3
$10K Buy
91
+89
+4,450% +$10.2K ﹤0.01% 1606
2021
Q2
$0 Sell
2
-20
-91% -$2.33K ﹤0.01% 2564
2021
Q1
$3K Buy
+22
New +$3.34K ﹤0.01% 1993

Other funds holding TWST

Quadrant Capital Group's TWST Position: Q2 2026 in Review

Quadrant Capital Group sold out of Twist Bioscience (TWST) in Q2 2026, closing a stake of 128 shares — an estimated $6.08K sold.

Quadrant Capital Group first reported a position in TWST in Q1 2021 and held it in 20 quarters. The position peaked at $12K in Q3 2022. 337 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Quadrant Capital Group reported no remaining Twist Bioscience position as of Q2 2026 after selling out during the quarter.
  • Quadrant Capital Group sold 128 Twist Bioscience shares in Q2 2026, an estimated $6.08K.
  • Quadrant Capital Group first reported a position in Twist Bioscience in Q1 2021 and held it in 20 quarters.
  • Quadrant Capital Group's Twist Bioscience position peaked at $12K in Q3 2022.
  • 337 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Quadrant Capital Group's 13F filing for Q2 2026, filed 14 Aug 2026.